Pharmacoeconomics of immunoglobulins in primary immunodeficiency
Explore this paper's citation graph
Summary
This article aims to review the use of immunoglobulin therapy in primary immunodeficiency by focusing on costs, effectiveness, cost–effectiveness, supply and off-label use.
- Type
- review
- Published
- 2009-08-01
- Cited by
- 17
- References
- 29
- OpenAlex
- https://openalex.org/W2087797117
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:35787592
Keywords
Primary immunodeficiency, Medicine, Common variable immunodeficiency, Antibody, Economic shortage
References
- Intravenous Immunoglobulin: Striving for Appropriate Use
- The effectiveness and cost effectiveness of immunoglobulin replacement therapy for primary immunodeficiency and chronic lymphocytic leukaemia: a systematic review and economic evaluation.
- A 10% ready‐to‐use intravenous human immunoglobulin offers potential economic advantages over a lyophilized product in the treatment of primary immunodeficiency
- Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology.
- Methods for the economic evaluation of health care programmes
- Pharmacoeconomic evaluation of immunoglobulin treatment in patients with antibody deficiencies from the perspective of the German statutory health insurance
- Economic assessment of different modalities of immunoglobulin replacement therapy.
- Quality of Life and Health-Care Resource Utilization Among Children with Primary Immunodeficiency Receiving Home Treatment with Subcutaneous Human Immunoglobulin
- Intravenous immunoglobulin: regulatory perspectives on use and supply
- Using the Delphi technique in economic evaluation: time to revisit the oracle?
- Immunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous route.
- Purification of intravenous immunoglobulin G from human plasma – aspects of yield and virus safety
- Responding to the Immunoglobulin Shortage: A Case Study
- Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature
- Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs.
- Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995–2000
- Immunoglobulin Replacement Therapy in Primary Antibody Deficiency Diseases – Maximizing Success
- Prescribing intravenous immunoglobulin: summary of Department of Health guidelines
- Cost savings from intravenous immunoglobulin manufactured from chromotography/caprylate (IGIV-C) in persons with primary humoral immunodeficiency disorder.
- Intravenous immunoglobulin utilization in the Canadian Atlantic provinces: a report of the Atlantic Collaborative Intravenous Immune Globulin Utilization Working Group
Cited by
- Gammaglobulina subcutánea en inmunodeficiencias primarias: experiencia del Instituto Nacional de Pediatría y revisión de la bibliografía
- Direct Medical Costs of Liquid Intravenous Immunoglobulins in Children, Adolescents, and Adults in Spain
- Home IVIG for CIDP: A Focus on Patient Centred Care
- Therapeutic Use of Immunoglobulins
- Prioritization of Evidence-Based Indications for Intravenous Immunoglobulin
- Safety and efficacy of Home-Based Subcutaneous Immunoglobulin G in Elderly Patients with Primary Immunodeficiency Diseases
- Payment, compensation and replacement – the ethics and motivation of blood and plasma donation
- Primary antibody deficiency syndromes
- Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program
- Costs of Hospital Admission on Primary Immunodeficiency Diseases
- Home-based subcutaneous immunoglobulin therapy vs hospital-based intravenous immunoglobulin therapy: A prospective economic analysis.
- Latent therapeutic demand model for the immunoglobulin replacement therapy of primary immune deficiency disorders in the USA
- Process steps for the fractionation of immunoglobulin (Ig) G depleted of IgA, isoagglutinins, and devoid of in vitro thrombogenicity.
- A clinician’s guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases
- Differences in immunoglobulin utilization when treating patients with primary immune disease in the United States
- The economic value of self-administered subcutaneous immunoglobulin G (SCIg) in Canada: a scoping review.
Related papers
- Thoracic Manifestations of Primary Immunodeficiency Disorders
- PROGRESSION OF PRIMARY SELECTIVE IgM DEFICIENCY TO COMMON VARIABLE IMMUNODEFICIENCY.
- A case of long-undiagnosed common Primary Immunodeficiency in adulthood.
- Common variable immunodeficiency disorders: What generalists should know
- [Primary immunodeficiency in adults: common variable immunodeficiency--clinical manifestations, immunological and genetic defects, treatment].
- Pediatric Systemic Lupus Erythematosus (SLE) As an Onset of Common Variable Immunodeficiency (CVID): The Double Link between Immunodeficiency and Autoimmunity
- Common Variable Immunodeficiency: A Paradox of Immunodeficiency and Autoimmunity
- Small intestine involvement in primary immunodeficiency